Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma.
Year: 1999
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: F Wang, E Bade, C Kuniyoshi, L Spears, G Jeffery, V Marty, S Groshen, J Weber
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2162057142
